Stephen Nimer, MD, Sylvester Comprehensive Cancer Center and University of Miami, Miami, FL, gives us his personal highlights from this year’s meeting. Specifically, the exciting drugs being developed to treat anemia and thrombocytopenia in patients with myelodysplastic syndromes (MDS). This interview took place at the 2nd Regional Symposium on Myelodysplastic Syndromes (MDS 2020), held in Tel Aviv, Israel.